Baobab AiBIO Co.
Latest round
- Series A
Last raised
- Mar 2021
Total raised
- $14M
Investors
- 7
About Baobab AiBIO Co.
, Ltd develops new drugs by synthesizing protein drugs mainly based on quantum mechanics. The company focuses on developing new drugs using quantum mechanical synthetic protein drug design technology, biological subspace hyperlinking technology, artificial intelligence-based PK prediction, and protein structure-based cryo-electron microscopy drug discovery technology. The pipeline currently under development includes BAB-104, BAB-107, etc.
Who invested in Baobab AiBIO Co.
7 investors across 1 round
See all investors in Baobab AiBIO Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 15, 2021
Amount
$14M
Investors
Questions about Baobab AiBIO Co.
Who invested in Baobab AiBIO Co.?
Baobab AiBIO Co. has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Baobab AiBIO Co. raised?
Baobab AiBIO Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Baobab AiBIO Co. last raise money?
Baobab AiBIO Co.'s most recent round on record is a Series A, in Mar 2021.
What does Baobab AiBIO Co. do?
, Ltd develops new drugs by synthesizing protein drugs mainly based on quantum mechanics.
Where is Baobab AiBIO Co. headquartered?
Baobab AiBIO Co. is headquartered in Incheon, South Korea.
Which VCs invest in companies like Baobab AiBIO Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Baobab AiBIO Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Baobab AiBIO Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.